Clinical Study of TBF Regimen in Allo-HSCT in Patients With CNS Leukemia

NCT05667402 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Central Nervous System Leukemia
Allogeneic Hematopoietic Stem Cell Transplantation

Interventions

DRUG: TBF regimen
DRUG: modified BuCY2 regimen

Sponsor

First Affiliated Hospital Xi'an Jiaotong University